The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report

Increasing cGMP is a unique therapeutic principle, and drugs inhibiting cGMP-degrading enzymes or stimulating cGMP production are approved for the treatment of various diseases such as erectile dysfunction, coronary artery disease, pulmonary hypertension, chronic heart failure, irritable bowel syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Friebe, Andreas, Kraehling, Jan R., Russwurm, Michael, Sandner, Peter, Schmidtko, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338386/
https://www.ncbi.nlm.nih.gov/pubmed/37079081
http://dx.doi.org/10.1007/s00210-023-02484-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338386/
https://www.ncbi.nlm.nih.gov/pubmed/37079081
http://dx.doi.org/10.1007/s00210-023-02484-8

Ejemplares similares